SBL Private
SBL is the only homoeopathic pharmaceutical company in India whose R&D Lab is recognized by The Ministry of Science & Technology, Government of India. Among others, we are the only company where every liquid formulation is subjected to microbiological test. In case of liquid preparations while the product may show no contamination at the time of manufacture, there is a great danger that during storage, the product may develop fungi and other serious contamination. We wish all homoeopathic manufacturers subject their liquid preparation to such microbiological tests. We are aware that creating microbiological laboratory can be costly. But, if we have to ensure the quality of our products, we should not spare the cost. Creating microbiological laboratory is a costly affair, but we have done so to ensure "WORLD CLASS QUALITY", with no increase in the price, so we mean "EXCELLENCE AT NO EXTRA COST". The company is continuously engaged in research work to not only improve its own products but also finding new formulations for serious diseases like diabetes. We have developed a combination which provides good control and management of NIDDM (Non insulin dependant diabetes mellitus). The product is still going through field test. Our research laboratory is also processing important ayurvedic herbs through homoeopathic method of manufacture. The results are most encouraging. The Government is opening up as a big buyer of medicine, what should be according to you the yardsticks and parameters for government purchase? We are aware that Government is one of the largest single buyer. Unfortunately, the entire procedure seem to be infested between the purchasers and suppliers - where the criteria is not to obtain the best quality medicines at the lowest cost, but to get the poor quality medicines at lowest price. Quality does not come cheap. Further, the objective of the Government to propagate the use of homoeopathy gets defeated because the poor quality medicines would not give the same rate of cure. If the government takes the decision to make sure that only quality medicines are purchased, it should be possible to list the quality manufactures in the country and then take bids only from such quality manufacturers. Unfortunately, the quality manufacturers are few in the country and other homoeopathic manufacturers are a crowd. Hence, our objective to see that the Government purchases only quality homoeopathic products, will take more time to sink in the minds of the persons sitting in the Chairs of Authority. As FOHMI President what message would you like to give to your fellow manufacturers? My humble message to all my fellow manufacturers in homoeopathy is to upgrade their manufacturing facilities so that the quality of the products they manufacture is at par with the set standards. This is essential because new GMP norms have been notified. In my view, because of the cost involved in the manufacture of quality mother tinctures (MT), many small manufacturers should not be manufacturing MT at all. They should source it from one of the quality manufacturers of MT. Similarly, since it is costly to manufacture "pure & perfect" back-potencies, they should also source the back-potencies from the manufacturers who have developed the necessary skills and also can afford to make necessary investments. In the case of liquid formulations, the cost involved is minimum. All such liquid formulations should be subjected to microbiological test. Regarding the tablets, at one time, most of the tablets in India were manufactured by hand dies.